Skip to main content
Journal cover image

Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experience.

Publication ,  Journal Article
Boutzoukas, AE; Olson, R; Sellers, MA; Fischer, G; Hornik, CD; Alibrahim, O; Iheagwara, K; Abulebda, K; Bass, AL; Irby, K; Subbaswamy, A ...
Published in: Contemp Clin Trials
February 2023

BACKGROUND: Timely trial start-up is a key determinant of trial success; however, delays during start-up are common and costly. Moreover, data on start-up metrics in pediatric clinical trials are sparse. To expedite trial start-up, the Trial Innovation Network piloted three novel mechanisms in the trial titled Dexmedetomidine Opioid Sparing Effect in Mechanically Ventilated Children (DOSE), a multi-site, randomized, double-blind, placebo-controlled trial in the pediatric intensive care setting. METHODS: The three novel start-up mechanisms included: 1) competitive activation; 2) use of trial start-up experts, called site navigators; and 3) supplemental funds earned for achieving pre-determined milestones. After sites were activated, they received a web-based survey to report perceptions of the DOSE start-up process. In addition to perceptions, metrics analyzed included milestones met, time to start-up, and subsequent enrollment of subjects. RESULTS: Twenty sites were selected for participation, with 19 sites being fully activated. Across activated sites, the median (quartile 1, quartile 3) time from receipt of regulatory documents to site activation was 82 days (68, 113). Sites reported that of the three novel mechanisms, the most motivating factor for expeditious activation was additional funding available for achieving start-up milestones, followed by site navigator assistance and then competitive site activation. CONCLUSION: Study start-up is a critical time for the success of clinical trials, and innovative methods to minimize delays during start-up are needed. Milestone-based funds and site navigators were preferred mechanisms by sites participating in the DOSE study and may have contributed to the expeditious start-up timeline achieved. CLINICALTRIALS: gov #: NCT03938857.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Contemp Clin Trials

DOI

EISSN

1559-2030

Publication Date

February 2023

Volume

125

Start / End Page

107067

Location

United States

Related Subject Headings

  • Time Factors
  • Public Health
  • Humans
  • General Clinical Medicine
  • Double-Blind Method
  • Child
  • Analgesics, Opioid
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Boutzoukas, A. E., Olson, R., Sellers, M. A., Fischer, G., Hornik, C. D., Alibrahim, O., … Becker, M. L. (2023). Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experience. Contemp Clin Trials, 125, 107067. https://doi.org/10.1016/j.cct.2022.107067
Boutzoukas, Angelique E., Rachel Olson, Mary Ann Sellers, Gwenyth Fischer, Chi D. Hornik, Omar Alibrahim, Kelechi Iheagwara, et al. “Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experience.Contemp Clin Trials 125 (February 2023): 107067. https://doi.org/10.1016/j.cct.2022.107067.
Boutzoukas AE, Olson R, Sellers MA, Fischer G, Hornik CD, Alibrahim O, et al. Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experience. Contemp Clin Trials. 2023 Feb;125:107067.
Boutzoukas, Angelique E., et al. “Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experience.Contemp Clin Trials, vol. 125, Feb. 2023, p. 107067. Pubmed, doi:10.1016/j.cct.2022.107067.
Boutzoukas AE, Olson R, Sellers MA, Fischer G, Hornik CD, Alibrahim O, Iheagwara K, Abulebda K, Bass AL, Irby K, Subbaswamy A, Zivick EE, Sweney J, Stormorken AG, Barker EE, Lutfi R, McCrory MC, Costello JM, Ackerman KG, Munoz Pareja JC, Dean JM, Abdelsamad N, Hanley DF, Mould WA, Lane K, Stroud M, Feger BJ, Greenberg RG, Smith PB, Benjamin DK, Hornik CP, Zimmerman KO, Becker ML. Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experience. Contemp Clin Trials. 2023 Feb;125:107067.
Journal cover image

Published In

Contemp Clin Trials

DOI

EISSN

1559-2030

Publication Date

February 2023

Volume

125

Start / End Page

107067

Location

United States

Related Subject Headings

  • Time Factors
  • Public Health
  • Humans
  • General Clinical Medicine
  • Double-Blind Method
  • Child
  • Analgesics, Opioid
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences